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Abstract 
Cancer is an illness that affects countless persons, either they themselves are 
afflicted or someone in their vicinity is. Research has shown that when 
glucosinolates – secondary metabolites in plants from the Brassicaceae family – 
are degraded in the stomach of animals via the enzyme (myrosinase), their 
metabolites can counteract the formation of tumour cells. However, the natural 
degradation in the stomach might not be sufficient, so it has been proposed that 
intake of microbes with myrosinase activity might be beneficial for the 
degradation of glucosinolates. This study was therefore conducted to search for 
microbes with myrosinase activity that might be safely digested.  
Chosen bacteria were first screened for glucosinolate breakdown based on a 
barium sulfate test which was inconclusive due to difficulties to discern the 
precipitate. Three bacterial strains were thought to be indicative of precipitation 
and were incubated with either sinigrin or mustard extract. Glucose was measured 
as an indicator for how much glucosinolate had been degraded during the 
incubation. Due to inconsistency between the results it was not possible to deduce 
whether glucosinolates were degraded or if the bacteria themselves produced 
glucose via an alternative pathway. 
Two strains of fungi were also tested for glucosinolate degradation using the 
barium sulfate screen containing sinigrin or vegetative extracts. L. maculans grew 
only on medium containing sinigrin while Botrytis grew indiscriminately on all 
media including the negative control.  
Due to the difficulties in attaining accurate results it would be wise to try to 
achieve more exact measuring methods for myrosinase activity should this 
research venue be continued. 
 
Resistance to antibiotics is a growing problem today that may cause havoc in the 
treatment of bacteria in the future. To solve this problem researchers have started 
looking towards marine organisms for antibacterial substances. The reason for the 
specific interest in marine organisms is that they represent a large biodiversity and 
have evolved separately from terrestrial animals for billions of years and should 
thus have novel molecules that could be used on new targets on bacteria. In this 
paper two samples from marine food processing were tested against several 
common microbes to see if they had any inhibitory effect. 
The samples were either filtrated or heat inactivated before screening 
against bacteria using an agar diffusion assay along with positive controls and 
untreated samples. The samples demonstrated an inhibitory effect against most of 
the chosen bacteria but it was thought to be of biological nature rather than 
chemical since the inhibition was only discerned when untreated samples were 
used on the bacteria plates. Two fungal strains were also tested but no inhibition 
was found when screened with the samples whether they were filtrated or not.  
The marine samples should be further tested since some inhibitory action 
against the bacteria could be found, but first it should be determined whether it is 
because of a new molecule or an already known structure. 
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Sammanfattning 
Cancer är en sjukdom som påverkar många människor, antingen är de själva sjuka 
eller känner någon som drabbats. Forskning har visat att när glukosinolater – 
sekundära metaboliter hos växter tillhörande Brassicaceae – bryts ner i magen på 
försöksdjur via ett enzym (myrosinas) kan deras metaboliter ha en inhibitorisk 
effekt på uppkomst av tumörceller. Den naturliga nedbrytningen kan dock vara 
för låg och därför har det föreslagits att intag av mikrober med myrosinas aktivitet 
kan vara gynnsam för nedbrytningen av glukosinolater. Denna studie utfördes 
därför för att finna mikrober med myrosinas aktivitet som kan ätas utan risk.  
Utvalda bakterier screenades för nedbrytning av glukosinolater via ett 
barium sulfat test vilket inte gav klara resultat pga. svårigheter att urskilja 
urfällning. Tre stammar förmodades dock kunna vara positiva för urfällning och 
inkuberades med sinigrin eller senapsextrakt. Glukoshalten mättes som en 
indikator för hur mycket glukosinolater som hade brutits ned under inkubationen. 
Variationer mellan resultaten gjorde det inte möjligt att påvisa om uppkomsten av 
glukos var pga. myrosinasaktivitet eller om bakterierna själva producerade glukos 
via en alternativ väg.  
Två svamparter testades även de för myrosinasaktivitet på medier 
innehållandes sinigrin eller växtextrakt via bariumsulfat testet. L. maculans växte 
enbart på medium som innehöll sinigrin medan Botrytis växte urskiljningslöst på 
alla medier inklusive den negativa kontrollen. 
Ska denna forskning fortgå vore det klokt att försöka hitta effektivare och 
mer exakta sätt att mäta myrosinasaktivitet eftersom det var svårt att få precisa 
resultat med metoderna i denna studie. 
 
Resistens mot antibiotika är ett växande problem idag som kan komma att orsaka 
problem i kampen mot bakterier i framtiden. För att lösa detta problem har 
forskare börjat söka efter antibakteriella ämnen hos marinlevande organismer. 
Anledningen till detta är att de har stor biodiversitet och har utvecklats separat 
från marklevande djur under miljarder år och borde därmed ha många oupptäckta 
molekyler som kan användas för att skapa nya antibakteriella måltavlor hos 
bakterier. I detta projekt screenades två marina provämnen mot flera vanliga 
mikrober för att undersöka om de hade en inhibitorisk effekt mot dem. 
Proven antingen filtrerades eller värmeinaktiverades innan de screenades via 
ett agar diffusions test mot bakterierna tillsammans med positiva kontroller och 
även obehandlade prov. Proven hade inhibitorisk effekt mot de flesta av 
bakterierna men antogs mer bero på någon biologisk komponent snarare än en 
kemisk eftersom inhibitionen endast uppstod när obehandlade prov användes. Två 
svampar testades även de, men proverna hade ingen effekt mot dem, vare sig de 
var filtrerade eller inte. 
Proverna borde fortsätta testas eftersom de utövade någon sorts inhibition 
mot bakterierna, men det borde först fastställas om inhibitionen är pga. en redan 
känd molekyl eller om det är en helt ny struktur. 
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Introduction 
Glucosinolates and Myrosinase 
Glucosinolates are organic 
compounds rich in sulfur that 
consist of three parts, a glucose, a 
sulfonated oxime group and a side 
chain that differs for each 
glucosinolate (Fig. 1). The side 
chain is derived from an amino acid 
and the glucosinolates are ordered 
into three major groups (aliphatic, 
aromatic or indolylic) dependent on 
which amino acid is used. The 
 
 
Fig. 1 Common structure of glucosinolates with the      
side chain (R) that varies for each 
glucosinolate. (Wikipedia)
amino acids belonging to the aliphatic group are Methionine, Leucine, Alanine, 
Isoleucine and Valine while Phenylalanine and Tyrosine are aromatic and 
Tryptophane belongs to the indolyl group  (Halkier et al. 2006).  
The glucosinolates are mainly observed in plants of the family Brassicaceae 
in the order Brassicales where they occur as secondary metabolites and are a 
major constituent in the plant’s protection against herbivores. When attacked the 
plant releases the glucosinolates which are subsequently hydrolyzed by 
myrosinase, a thioglucohydrolase (EC3.2.1.147), thus producing metabolites that 
can either be toxic to the assailant, simply deterring due to bad taste or smell or 
they can attract natural enemies that are predatory against the plant assailant 
(Rask et al. 2000, Mikkelsen et. al. 2001). 
Biosynthesis of Glucosinolates 
Glucosinolates are synthesized in three steps; chain elongation, core synthesis and 
secondary modifications. The core synthesis is the same for all glucosinolates 
while chain elongation occurs only for certain amino acids and the secondary 
modifications vary for each glucosinolate (Grubb & Abel 2006). This gives rise to 
an extensive diversity of glucosinolates with >120 different structures known 
today (Fahey et al. 2001). 
The chain elongation starts by deamination of the amino acid thus producing 
an α-keto acid, which further reacts with acetyl-CoA to form a 2-malate 
derivative. This structure is further processed via isomerization to produce a 3-
malate derivative that is elongated by a methylene through oxidative 
decarboxylation. The resulting elongated α-keto acid can be further extended by 
another round of the three-step sequence to gain an additional methylene or it can 
be transaminated and then proceed to the next step, core synthesis (Fig. 2). The 
side chain can be elongated up to nine times before it proceeds to core synthesis 
(Mikkelsen et al. 2001, Wittstock & Halkier 2002, Halkier et al. 2006).   
In the core synthesis the amino acid (either from the elongation route or 
non-processed) is converted to an aldoxime by oxidation by cytochrome P450s of 
the CYP79 family, then the aldoxime is oxidized  by cytochrome P450s in the 
CYP83 family to produce an highly unstable intermediate, either an aci-nitro 
compound or a nitrile oxide. These compounds then spontaneously react with 
thiols (probably from cysteine) to produce an S-alkyl thiohydroximate. This 
conjugation is believed to be enzymatically controlled by a glutathione-S-
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transferase-like enzyme. Next the S-Alkyl thiohydroximate is cleaved by C-S 
lyase to form a thiohydroximic acid which is then glucosylated by  
 
 
Fig. 2 Side chain elongation.  
The amino acid is deaminated to produce a 2-oxo acid which is condensed with acetyl-CoA 
to produce a 2-Malate derivative that is isomerized to generate a 3-Malate derivative. The 
3-Malate derivative undergoes oxidation-decarboxylation that adds a methylene and thus 
creates an extended 2-oxo acid that can either undergo further elongation or be 
transaminated to start core synthesis. The carbons in red are the ones contributed by the 
acetyl-CoA and the ones in blue are from the original COO
-
 (Halkier et al. 2006). 
 
thiohydroximate glucosyltransferase to produce a desulfoglucosinolate that in turn 
is sulfated by desulfoglucosinolate sulfotransferase to form a glucosinolate (Fig. 
3) (Mikkelsen et al 2002, Halkier et al. 2006, Grubb et al. 2006). 
The parent glucosinolate can be further altered by secondary modifications 
that occur on the side chain. These modifications are crucial since they determine 
the nature of the products formed after degradation of the glucosinolate by the 
myrosinase enzyme (Halkier et al. 2006). The side chains can undergo oxidation, 
elimination, alkylation, esterification, hydroxylation, methoxylation, desaturation 
or glycosylation (Mikkelsen et al. 2001, Grubb et al. 2006, Halkier et al. 2006, 
Rask et al. 2000). Especially side chains derived from methionine are prone to 
undergo further modifications (Halkier et al. 2006, Grubb et al. 2006).  
Degradation 
Upon hydrolysis by the myrosinase the glucosinolate forms glucose and an 
unstable intermediate, thiohydroximate-O-sulfate. This intermediate then 
undergoes further transformation to yield the active metabolite; isothiocyanate, 
nitrile, thiocyanate, epithionitrile, oxazolidine-2-thione or other less common 
products (Fig. 4.). The structure of the final product(s) is dependent on chain 
elongation, secondary modifications, myrosinase interacting proteins (e.g. 
epithiospecifier proteins (ESP)), co-factors and physical circumstances such as pH 
(Grubb et al. 2006, Rask et al. 2000, Halkier et al. 2006, Bones & Rossiter 2006). 
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Fig. 3 Core synthesis of glucosinolates.  
The amino acid is oxidized to an aldoxime by CYP79 enzymes. The aldoxime is then 
further oxidized to S-Alkyl thiohydroximate by enzymes in the CYP83 family. The S-Alkyl 
thiohydroximate is cleaved by C-S lyase before being glucosylated and sulfated (Halkier & 
Gershenzon 2006). 
Anti-carcinogenic effect 
For several years it has been shown that certain glucosinolate metabolites have an 
anticarcinogenic effect on animals and humans. Various mechanisms for this 
effect have been proposed and they mostly involve isothiocyanates. Certain 
isothiocyanates can lower the risk for cancer by inducing phase 2 enzymes, which 
neutralize reactive compounds that might otherwise cause mutagenesis 
(Verhoeven et al. 1997, Talalay & Fahey 2001, Keum et al. 2004). It has as well 
been shown that allyl isothiocyanate that originates from sinigrin can reduce 
metastasis by inhibiting metallo proteinases. The metallo proteinases degrade the 
extracellular matrix (ECM), which is the first step in the process of metastasis 
(Hwang & Lee 2006). Isothiocyanates can also induce apoptosis, e.g. phenethyl 
isothiocyanate induces c-Jun N-terminal kinase, which has a major role in 
apoptosis caused by e.g. mutagenic substances (Keum et al. 2004).  
Most of the anticarcinogenic effect of glucosinolates is attributed to their 
metabolites, however the majority of humans eat their vegetables cooked and 
during the heating the myrosinase responsible for the degradation is inactivated. It 
has been reported that intestinal micro flora in humans have myrosinase activity, 
but it would be beneficial if additional myrosinase-containing bacteria could be 
taken separately to enhance the production of glucosinolate metabolites in the 
intestines. 
In this study several bacteria reported to have degraded glucosinolates were 
re-tested for myrosinase activity; Lactobacillus agilis R16 (Palop et al. 1995), 
Bifidobacterium pseudocatenulatum, Bifidobacterium adolescentis, 
Bifidobacterium longum (Cheng et al. 2004) and Bacteriodes Thetaiotaomicron 
(Elfoul et al. 2001). Several previously untested strains of Lactobacilli (listed in 
material and methods) were also screened for myrosinase activity. 
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Fig. 4 General outline of glucosinolate degradation. (Rask et al.  2000) 
Marine biological waste products from food processing 
In today’s world the over-consumption of antibiotics cause an escalating problem 
of multi-drug resistant bacteria e.g. Staphylococcus aureus and Pseudomonas 
aeruginosa.  
S. aureus was first treated with penicillin until resistance was reported in the 
1940s. The penicillin resistant strain soon invaded the world and caused huge 
problems due to its strong virulence and high mortality. In 1960, meticillin was 
introduced to the market and it was very effective against the penicillin resistant S. 
aureus strain. Nonetheless, already in 1967 multi-drug resistant MRSA (meticillin 
resistant S. aureus) started to appear and in 1990s 22 epidemic MRSA strains 
were identified (Shito 2006, Grundmann et al. 2006). Due to the resistances 
glycopeptides such as vancomycin have been the main treatment against MRSA. 
However S. aureus strains resistant against vancomycin has been found during the 
last couple of years (Shito 2006, Grundmann et al. 2006, Beović 2006). 
Another bacterium that is known for its antibiotic resistance is P. 
aeruginosa. The main constituent that enables P. aeruginosa’s multi-drug 
resistance is its capability to produce a wide variety of β-lactamases (Bonomo & 
Szabo 2006) and it may be resistant to all available antibiotics (Beović 2006). 
Existing antibiotics focus primarily on four targets in bacteria; disruption of 
the cell wall, interference with enzymes essential for the bacteria, inhibition of 
DNA synthesis or obstruction of ribosomal activity (Murray et al. pp 204-205, 
Brown & Wright 2005). To overcome the effects of antibiotics bacteria employ 
five strategies; modification of the target site, a lesser intake of the antibiotic by 
reduced permeability of the cell, excretion of the antibiotic by efflux pumps, 
inactivation of the antibiotic or alterations in the cell to produce resistant 
metabolic pathways (Murray et al. p. 720). The need for new antibiotic targets is 
urgent; however, there are certain preferences that an antibiotic target should 
fulfill to be worth pursuing; it should not be present in human cells, it should 
preferably be an enzyme with a well known function and the target should be vital 
for survival (Brown & Wright 2005). 
The arising multi-drug resistant bacteria highlight the need for other 
antibacterial substances. Today approaches have been made to discover new 
antibacterial material from extreme environments such as hot springs or from 
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oceans instead of the traditional usage of soil bacteria or development of synthetic 
antibiotic molecules.  
Reasons for this focus on the marine environment are that the organisms 
there have an extensive biodiversity (Sogin et al. 2006, Bhadury et al. 2006) – due 
to large variations in their living conditions (Kennedy et al. 2008, Bhadury et al. 
2006) – and have evolved separately from terrestrial animals for 3,5 billions of 
years (Sogin et al. 2006) and should thus have novel biomolecules and pathways 
(Kennedy et al. 2008, Bhadury et al. 2006, Salomon et al 2004). Terrestrial 
microorganisms might be sensitive to these marine biomolecules since they would 
not have encountered them before and thus not have a self-defense against them.  
In this study two substances, which have shown positive signs of being 
antibacterial in field studies (not published), derived from marine food processing 
(“biological waste products”) and obtained from Lars Forsén (Glanshammar), 
were screened against four different human pathogenic bacteria and two fungal 
strains to observe potential antimicrobic effect.  
Aim of the present study 
 To measure glucosinolate concentration in extracts of mustard seeds and 
cabbage 
 To identify microorganisms with myrosinase activity 
 To identify possible antimicrobial effects of marine biological waste 
products from food processing on various bacterial strains and fungi 
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Material and methods 
Glucosinolates and myrosinase 
Media 
Media used for growth or screening of bacteria were MRS with agar and glucose 
(MRS) or without them (MRS-A-G) or with either one (MRS-G or MRS-A) (10g 
Casamino acids, 10 g beef extract, 5 g yeast extract, 1 g Tween-80, 2 g K2HPO4, 5 
g sodium acetate, 1.33 g tri-ammonium citrate, 0.2g magnesium sulfate∙7H2O, 
0.05g manganese sulfate ∙ H2O, 20g D(+)-glucose, 15g agar and milliqQ water 
(MQ H2O) to a final volume of 1L), PDA( Duchefa Biochem), PDB, Barium 
medium (5 mM ammonium chloride, 2.5 mM barium chloride, 3.15 g agar and 
MQ H2O to a final volume of 200 mL), BHI-agar (47 g BHI agar (Oxoid), 5 g 
yeast extract and MQ H2O to a final volume of 1L. 2.5 mg haemin was added to 
half of the medium before plating), BHI-broth (37 g BHI-broth, 5 g yeast extract, 
5 mg haemin and MQ H2O to a final volume of 1L) and MRS without glucose, 
with agar and with 0.2 g magnesium chloride∙6H2O instead of magnesium sulfate 
and 0.05 g manganese chloride instead of manganese sulfate (will be called MRS-
G-SO4). 
Glucosinolate extract from mustard seeds 
At four different times 200 g of mustard seeds (Maxi) were ground, 50 g at a time 
for 2×10 s with 3 pulses (each 1s) in between, in a small blender/coffee grinder, 
poured into 500 mL of boiling methanol (99.8 %) and boiled for 5 min. The 
following steps varied slightly for each time: the first mixture was left to cool for 
40 min whereupon all methanol had evaporated and an additional amount of 300 
mL of boiling methanol was added before filtration through a Munktell filter 
paper; the second mixture was only left to cool for 5 min before proceeding with 
filtration so no additional methanol was added; from the third mixture most of the 
methanol had been taken up by the seeds or evaporated after a cooling period of 
20 min so 350mL of boiling methanol was added before filtration; when the 
fourth mixture was left to cool (10 min) it was covered in saran wrap to avoid 
evaporation so no additional methanol was added before the filtration. The 
methanol was evaporated by Rotavapor and the filtrate was then rehydrated with 
0.02 M Sodium acetate, pH 5. Here, there were again some variations in the 
procedures, filtrates one and two were pooled together and no further purifications 
were made before separation on ion exchange columns. Filtrate three was further 
purified by centrifugation (10,000 rpm (16,500 g) for 20 min at 12°C and 2× 
20,000 rpm (50,300 g) for 10 min at 4°C) as was filtrate four (11,749 rpm (16,500 
g) for 20 min at 4°C) before being filtrated once again with Munktell filter paper 
and also 0.45 and 0.2 μm Millipore filters. All filtrates were stored air tight at 4°C 
in darkness. 
Glucosinolate extract from cabbage 
A small cabbage head was cut into 1×1 cm pieces after removal of the outer 
leaves, left out in room temperature for ~72 hours, crushed with 2 L of boiling 
methanol (99. 8%) for 20 seconds in a blender, boiled for an additional 5 min and 
filtrated through a Munktell filter paper before removal of the methanol from the 
filtrate by rotavapor.  
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Glucosinolate extracts from various strains of cress 
Glucosinolate extracts from different kinds of cress from previous experiments 
were also used. The extracts were made using the same method as in the cabbage 
extraction. The cresses used and the glucosinolate concentrations were; Indian 
cress (roots) in methanol, 2.89μg/mL, Watercress (roots) in methanol, 
1.635μg/mL, Wintercress (shoots) in methanol 5.985μg/mL and Tindora (roots) in 
methanol 1.431μg/mL. 
Ion exchange chromatography 
The ion exchange gel was prepared by adding Sephadex (A-25) to an excess of 
0.5 M Sodium acetate, pH 5. The solution was filtered through a Munktell filter 
paper and resuspended in 0.5 M Sodium acetate, pH 5. This was repeated once 
more (without resuspending the last time) before the gel was washed with MQ 
water and resuspended in twice the gel volume of 0.02 M Sodium acetate, pH 5. 
The columns were made by putting glass fiber at the bottom of 50 mL syringes 
and adding ~35 mL of the Sephadex. 
The glucosinolate filtrates (mustard and cabbage) were added to the columns 
and the bound glucosinolates were eluted by the addition of methanol (60 %). 
Both flow through and elution fractions were stored at 4°C in dark for further 
analysis using spectrophotometry.   
Measurement of glucose concentration in glucosinolate extracts 
When glucose concentration was measured in mustard (pooled filtrates one and 
two) and cabbage, samples were taken from both flow through and elution and 
diluted with 0.02 M sodium acetate, pH 5 or methanol (60 %) respectively to 
concentrations of 100 %, 75 %, 50 % and 25 %. From each concentration 5×62 
μL was taken and to four of them Myrosinase (0.5 μL myrosinase in 24.5 μL 50 
mM sodium citrate, pH 4.5) was added, while the fifth was kept as a blank and to 
which only 25 μL of 50 mM sodium citrate was added. The samples were 
incubated for 2 h at 37°C before being heat inactivated at 95°C for 5 min. Two 
series of glucose standards were prepared with either solvent i.e. 0.02 M Na-
acetate or methanol (60 %). The glucose standard (Randox) contained 5.55  
nmol/μL of glucose and 2, 3, 5, 10, 15 and 20 μL of the standard were diluted 
with either solvent to a final volume of 87 μL while a negative control was also 
prepared consisting of pure solvent. 250 µL of glucose test reagent was added to 
all samples and standards which were then incubated for 15 min at 37°C before 
absorbance at 550 nm was measured.  
Two concentration time lines were made, the first using a different 
concentration for each fraction (cabbage flow through 75 %, cabbage elute 75 %, 
mustard flow through 25 % and mustard elute 50 %) and incubation times of 2 h, 
4 h and 65 h while the other used a concentration of 10 % for all fractions and 
shorter incubation times, 0.5 h, 1 h, 2 h, 4 h and 24 h. Concentration time lines 
were also made for filtrate three and four (mustard) with a concentration of 10 % 
for all fractions and incubation times of either 0.5 h, 1 h, 2 h, and 4 h (filtrate 
three) or 0.5 h, 1 h, 2 h, and 3 h (filtrate four). 
Screening for glucosinolate breakdown 
Plates containing 6 mL of Barium medium and either 5.78 μg Indian cress root in 
methanol, 3.27 μg Water cress root in methanol, 11.97 μg winter cress shoot in 
methanol, 2.863 μg Tindora shoot in methanol or 5 mM purified sinigrin from 
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horseradish were cast plus a negative control containing only barium medium. 
Upon these plates 5 μL of Leptosphaeria maculans (Leroy) spores in water were 
spread and incubated using a regime of 22°C in light 16 h, and 16°C in dark 8h 
for six days. 
L. agilis R16 (TNO, MTA) colonies grown on MRS-G plates were spread 
upon plates, containing either only MRS-G-SO4 or MRS-G-SO4 with 2.5 mM 
barium chloride or MRS-G-SO4 with 2.5 mM barium chloride and 5 mM sinigrin, 
and incubated at 28°C for three days. 
Plates containing MRS-G-SO4 with 2.5 mM barium chloride and different 
concentrations of sinigrin (5 mM, 1 mM and 0.25 mM) plus two negative controls 
containing MRS-G-SO4 with or without 2.5 mM barium chloride were used for 
screening B. thetaiotaomicron (RIKEN JCM no 5827), B. pseudocatenulatum 
(RIKEN JCM no 7040), B. adolescentis (RIKEN JCM no 7045), B. longum 
(RIKEN JCM no 7050), Lactobacillus Johnsonii (SLU 1.30), Lactobacillus 
coryniformis (SLU M333 14147), Lactobacillus plantarum (SLU H92:3), 
Lactobacillus saeri…neri (SLU GDA 154), Lactobacillus mucosae (SLU S32), 
Lactobacillus reuteri (SLU DSM 17938), Lactobacillus reuteri (SLU MM4-1A), 
Lactobacillus acidophilus schaedler (SLU 5.89), Lactobacillus salivarius (SLU 
5.83), Lactobacillus murimase-like (SLU Na3 2.34), Lactobacillus salivarius 
schaedler (SLU 5.90), Lactobacillus “new specie rat” (SLU Na1 1:43) and 
Lactobacillus “new specie 2 rat” (SLU 2:38). Before the screening the B. 
thetaiotaomicron and the Bifidobacteria were cultured anaerobically on BHI-
plates at 37 °C. The B. thetaiotaomicron, the Bifidobacteria and the Lactobacilli 
were grown at 37°C for a week. While the Lactobacilli were grown both 
anaerobically and aerobically the B. thetaiotaomicron and the Bifidobacteria were 
only grown anaerobically. 
Botrytis was screened for myrosinase activity by spreading 5 μL of spores in 
water on plates containing pure barium medium (neg. ctrl) and on plates also 
containing either 5 mM sinigrin, 1.3 mL extract (mustard flow through or elution 
(filtrate one and two), Indian krasse, Vattenkrasse or Vinterkrasse) per 4 mL 
medium or 0.5 mL Tindora extract per 1.5 mL medium. The plates were incubated 
using regime of 22°C in light 16h and 16°C in dark 8h. 
L. maculans (Leroy) was screened with the same substances and 
concentrations as Botrytis except for the Tindora extract.  
100 μL of L. Johnsonii, L. plantarum, L. “new strain 2 rat” and L. agilis R16 
were inoculated, in 10 mL of MRS-G (neg. ctrl) and MRS-G containing 1 mM 
sinigrin, and incubated at 37°C on a circular shaker (150-220 rpm) for 2 h, 6 h, 24 
h and 48 h. The samples taken at the different time points were spun down 
(13,000 rpm for 10 min) and the supernatant saved. The glucose content was 
measured for each sample by adding glucose test reagent, incubating for 15 min at 
37°C and then measuring the absorbance at 550 nm as described above. The 
bacteria were also inoculated in MRS-G containing 1 mM flow through fraction 
from filtrate four (the flow through had first been freeze dried and resuspended in 
MQ H2O). Samples were taken at 2 h, 6 h and 24 h and processed and measured 
as before, but this time the pellets from 6 h and 24 h were saved and a viable 
count was made. The pellets were rehydrated with MQ H2O and diluted to four 
concentrations, 100 %, 10 %, 1 % and 0.1 % which were spread on MRS plates 
and incubated over night at 37°C.  
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Antibacterial effects of marine biological waste products from 
food processing 
Growth media 
Nutrient agar, LB medium with and without agar (10 g bacto-tryptone, 5 g yeast 
extract, 5 g NaCl, 15 g agar and MQ H2O to a final volume of 1L) and blood agar 
were used for growth and screening. 
Marine biological waste products 
Samples from the marine biological waste products obtained from food processing 
industry were filtered through Munktell filter paper, 0.45 μm and 0.2 μm 
Millipore filters, then spread on MRS, BHI and LB plates to check for bacterial 
growth and incubated at 37°C for a couple of days. The pH values of both filtrates 
were measured to ~5. Half of the filtrates were also freeze dried to achieve higher 
concentration.  
Cultures of Bacillus amyloliquefaciens, strains UCMB 5036, 5033 and 5113 
were filtrated (0.2 μm Millipore filter) and then incubated to check for bacterial 
growth before use. 
Screening for antibacterial effect 
Sterile paper circles saturated with diluted (0, 1:1, 1:10, 1:100, 1:1000, 1:10 000) 
filtrates of marine biological waste products, negative control (MQ H2O) and two 
positive controls (Spectinomycin 10 mg/mL and Kanamycin 50 mg/mL) were 
placed on nutrient plates containing Escherichia coli, Staphylococcus epidermidis, 
Pseudomonas or Staphylococcus aureus. The plates were then incubated at 37°C 
for up to a week. These four bacteria were also screened on LB plates against 
unfiltered marine waste products, heat inactivated unfiltrated marine biological 
waste products, filtrate of B. amyloliquefaciens strain 5036 and honey and on BHI 
plates against concentrated filtrate of marine biological waste products and 
filtrates of B. amyloliquefaciens strains 5033 and 5113 at 37°C. 
New strains of P. aeruginosa, E.coli and S. aureus (8325-4) were obtained 
and tested against unfiltrated and concentrated filtrate of marine biological waste 
products, filtrates of B. amyloliquefaciens strains 5036, 5033 and 5113, 
Kanamycin and Spectinomycin on BHI plates at 37°C. 
Bipolaris sorokiniana on PDA plates were screened against unfiltrated, 
filtrated and concentrated filtrate of marine biological waste products, B. 
amyloliquefaciens strains 5036, 5033 and 5113, Spectinomycin and Kanamycin at 
daily rhythm conditions. The effect of unfiltrated biological waste products 1 and 
2, Spectinomycin, Kanamycin, B. amyloliquefaciens strains 5036 and 5033 on 
Botrytis growing on PDA plates were also tested under daily rhythm conditions. 
Staphylococcus equi grown on blood agar plates were also screened against 
all of the substances above except filtrated marine biological waste products and 
honey. 
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Results 
Glucosinolates and myrosinase 
Glucose concentration in the glucosinolate extracts 
To determine the glucosinolate content of the various extracts after ion exchange 
chromatography, samples from the flow through and the elution fractions were 
incubated with myrosinase. Thereafter, a commercial reagent was added that 
converts the released glucose into a colored product measured at 550 nm. 
When measuring the pooled mustard extract for the first time it was diluted 
to four concentrations (100, 75, 50 and 25 %) for future references plus a blank 
and the concentrations were incubated for two hours at 37°C with the myrosinase. 
However, the concentrations were so high in some cases that they exceeded the 
linear scale (appendix A). The concentrations shown are for the diluted extracts 
(Fig. 5). The values obtained for the undiluted and the 75 % extracts are not 
shown in the diagram because the glucose amount in the blank exceeded the test 
samples. As can be seen, the flow through fraction contains more glucose than the 
elution fraction. 
The same procedure was followed for the cabbage extract.  However, the 
results were inconclusive since the readings exceeded the scale to up the double 
the amount so no diagram was made (appendix B). 
A concentration time line was made for both the mustard and cabbage 
extract where a different concentration was used for each fraction. The incubation 
times with myrosinase were 2, 4 and 65 h. Unfortunately, these glucose 
concentrations also exceeded the scale limit (appendix C and D). Therefore a new 
concentration time line was made where all fractions for both extracts were kept 
at 10 % and shorter incubation times were used; 0.5, 1, 2, 4 and 24 h . Again the 
glucose content was higher in the flow through fraction than in the elution fraction 
in the mustard extract. An increase in glucose concentration could be seen in the 
elution fraction at 1 – 2 h, which then decreased again at 3 h and forward (Fig. 6, 
appendix E).  
Glucose concentration in mustard extracts at different concentrations of 
extract
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MF 100 MF 75 MF 50 MF 25 ME 100 ME 75 ME 50 ME 25
Fraction and concentration (%)
 
Fig. 5 Glucose concentration in pooled mustard extract. MF and ME denotes flow through 
fraction and elution fraction respectively. The number means the extract concentration in 
percent. The glucose concentration is that of the diluted extract. 
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When a fraction concentration of 10 % was used, some measurable results could 
be obtained from the analysis of the cabbage extract, but only from the flow 
through fraction. However, the results were inconclusive due to large differences 
between the samples (Fig. 7). The incubation times and samples missing is due to 
the blank that apparently had a higher glucose concentration than the samples. 
The elution fraction once again exceeded the scale (appendix F). 
 
Glucose concentration in 10% mustard extract fractions 
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Fraction and incubation time (h)
 
Fig. 6 Concentration time line for pooled mustard extract with a fraction concentration of 
10%. MF and ME denotes flow through fraction and elution fraction respectively. The 
number represents the incubation time (h) 
 
Glucosinolate concentration in cabbage after different 
incubation times
0
5
10
15
20
25
30
35
CF 1 CF 4
Fraction and incubation time
 
Fig. 7 10% concentration time line for cabbage extract. CF represents flow through fraction 
and the numbers correspond to the incubation time (h). 
 
A concentration time line was also made for mustard extract three with 10% 
fraction concentration and incubations times of 0.5, 1, 2 and 4 h (Fig. 8). While 
some glucose was detected in the flow through fraction it was only a tenth of the 
glucose amount found in pooled extract one and two and no glucose was 
measured in the elution fraction (appendix G). 
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Glucose concentration in 10%  mustard extract 3
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Fig. 8. Concentration time line for mustard extract three with a fraction concentration of 
10%. MF denotes flow through fraction and the number stands for incubation time (h) 
 
The concentration time line for the flow through fraction from extract four at 10 
% concentration almost reached the same glucose level as pooled extract one and 
two, but only between 1 – 2 h of incubation, otherwise it was very low. The 
glucose content in the elution fraction was not anywhere near the value of the 
pooled extract (Fig. 9, appendix H). 
 
Glucose concentration in 10% mustard extract 4
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Fig. 9 Concentration time line for mustard extract four with a fraction concentration of 
10%. MF represents flow through fraction and the number stands for incubation time (h). 
Screening for glucosinolate breakdown 
L. maculans spores were spread on medium plates containing barium and different 
glucosinolate substrates to screen for potential myrosinase activity. L. maculans 
was positive for sinigrin degradation, which was revealed by the opaque barium 
sulfate area around the fungi as previously described by Sakorn et al. (2002).  
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Fig. 10 Screening for glucosinolate degradation in L. maculans. The substrates are from top left 
to bottom right: Sinigrin, neg. control, mustard extract flow through fraction, mustard 
extract elution fraction, Indian cress, Water cress and Winter cress.  
 
However, no growth was observed on the plates containing other glucosinolate 
substrates nor on the negative control (Fig. 10). 
Botrytis was also screened against the same glucosinolate extracts as L. 
maculans. However Botrytis grew on all plates including the negative control 
(blank) albeit it can be difficult to see in the picture (Fig. 11). 
 
 
Fig. 11 Screening for myrosinase activity in Botrytis. The substrates are from top left to bottom 
right: Sinigrin, neg. control, mustard extract flow through fraction, mustard extract 
elution fraction, Indian cress, Water cress, Winter cress and Tindora.  
 
The L. agilis strain R16 that previously had been shown to have a 
degradative effect on sinigrin, was also screened, but on MRS plates lacking 
sulfate and glucose but containing either barium or sinigrin and barium. The 
results were that the bacteria grew on all three substrates (pictures not shown). 
All the other bacteria were similarly tested for myrosinase activity. However 
only three bacteria (L. johnsonii, L. plantarum and L. “new species 2 rat”) showed 
some signs of potential degradation of sinigrin (Fig. 12).   
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Fig. 12 Results of screening for myrosinase activity.  
From left to right: L. plantarum (5mM sinigrin), L. plantarum (neg. ctrl with barium), L. 
johnsonii (0,25mM sinigrin), L. johnsonii (neg. ctrl with barium), L. “new species 2 rat” 
(5mM sinigrin) and L.” new species 2 rat” (neg ctrl with out barium). 
 
These three species were further tested by incubation in MRS-G containing either 
sinigrin or mustard flow through fraction from extract four. Samples were taken at 
different time points and the glucose content was measured using 
spectrophotometry. A higher amount of glucose was found when the bacteria were 
induced by sinigrin than when the flow through fraction was used as can be seen 
in tables 1 and 2. 
 
Table 1. Glucose content  in medium after induction with 1 mM of sinigrin. B represents blank 
(negative control). 
Sample Mean abs. 
Mean  abs - 
B abs. 
Glucose 
(nmol) 
Sample - B 
(nmol) Sample 
Mean 
abs. 
Mean  abs - 
B abs. 
Glucose 
nmol 
Sample - 
B (nmol) 
                    
Neg. Ctrl 0.134   0   Neg. Ctrl 0.134   0   
Stand. 1 0.176   5.55   Stand. 1 0.176   5.55   
Stand. 2 0.21   11.1   Stand. 2 0.21   11.1   
Stand. 3 0.277   16.65   Stand. 3 0.277   16.65   
Stand. 5 0.335   27.75   Stand. 5 0.335   27.75   
Stand. 10 0.521   55.5   Stand. 10 0.521   55.5   
Stand. 15 0.7   83.25   Stand. 15 0.7   83.25   
Stand. 20 0.949   111   Stand. 20 0.949   111   
John. 2 0.198 0.05 8.533 7.044 R16 2 0.076 - -8.655 - 
John. 2 B 0.148   1.489   R16 2 B 0.075   -8.796   
John. 6 0.133 - -0.624 - R16 6 0.147 - 1.348 - 
John. 6 B 0.138   0.08   R16 6 B 0.267   18.255   
John. 24 0.825 - 96.871 - R16 24 1.17 1.027 145.479 144.695 
John. 24 B 0.084   -7.528   R16 24 B 0.143   0.784   
John. 48 0.924 0.171 110.82 24.093 R16 48 1.83 1.561 238.466 219.929 
John. 48 B 0.753   86.727   R16 48 B 0.269   18.537   
Plant. 2 0.129 - -1.188 - New spec (2) 2 0.618 0.073 67.707 10.285 
Plant. 2 B 0.113   -3.442   New spe(2) 2 B 0.545   57.422   
Plant. 6 0.654 0.118 72.779 16.625 New spec (2) 6 0.497 0.047 50.66 6.622 
Plant. 6 B 0.536   56.154   New spe(2) 6 B 0.45   44.038   
Plant. 24 0.708 0.062 80.387 8.735 New spec(2) 24 0.085 - -7.387 - 
Plant. 24 B 0.646   71.652   New sp(2) 24 B 0.058   -11.191   
Plant. 48 1.15 0.099 142.661 13.948 New spec(2) 48 0.304 0.233 23.468 - 
Plant. 48 B 1.051   128.713   New sp(2) 48 B 0.071 - -9.36   
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Table 2. Glucose content in medium after induction with mustard extract (4) flow through 
fraction.  
Sample Mean abs. 
Mean  abs 
- B abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) Sample 
Mean 
abs. 
Mean  abs - 
B abs. 
Glucose 
(nmol) 
Sample. - 
B (nmol) 
Neg. Ctrl 0.269       Neg. Ctrl 0.269       
Stand. 1 0.288   5.55   Stand. 1 0.288   5.55   
Stand. 2 0.307   11.1   Stand. 2 0.307   11.1   
Stand. 3 0.3337   16.65   Stand. 3 0.337   16.65   
Stand. 5 0.419   27.75   Stand. 5 0.419   27.75   
Stand. 10 0.597   55.5   Stand. 10 0.597   55.5   
Stand. 15 0.816   83.25   Stand. 15 0.816   83.25   
Stand. 20 1.062   111   Stand. 20 1.062   111   
John. 2 0.739 0.157 70.663 21.428 R16 2 0.349 0.126 17.435 17.197 
John. 2 B 0.582   49.235   R16 2 B 0.223   0.238   
John. 6 0.365 - 19.619 - R16 6 0.108   -15.457 - 
John. 6 B 0.15   -9.725   R16 6 B 0.161   -8.224   
John. 24 0.163 - -7.951 - R16 24 1.897 - 228.71 - 
John. 24 B 0.154   -9.179   R16 24 B 2.507   311.964   
Plant. 2 0.592 0.112 50.6 15.286 New spec (2) 2 0.614 0.112 53.603 15.286 
Plant. 2 B 0.48   35.314   New spe(2) 2 B 0.502   38.317   
Plant. 6 0.739 - 70.663 - New spec (2) 6 0.463 - 32.994 - 
Plant. 6 B 1.932   233.487   New spe(2) 6 B 0.544   44.049   
Plant. 24 1.998 - 242.495 - New spec(2) 24 1.803 - 215.88 - 
Plant. 24 B 2.449   304.048   New sp(2) 24 B 2.261   278.389   
 
The bacterial pellets from the samples taken at 6 and 24 h from the mustard 
induction were rehydrated and diluted to four concentrations (100, 10, 1 and 0.1 
%) which were spread onto MRS plates to make a viable count analysis. The 
results (Table 3) show that most of the bacteria survived in the negative control. 
 
Table 3.  Viable count of the bacteria that were induced by mustard extract. The number in 
the parenthesis represents the time point when they were collected, 2 = 6 h and 3 = 24 
h. The percentage is their concentration. 
Sample 
(positive) VC 
Sample 
(Blanks) VC 
Sample 
(pos.) VC 
Sample 
(pos.) VC 
Sample 
(B) VC 
Sample 
(pos.) VC Sample (B) VC 
                            
 John. (2) 
1% ~700     
 Plant. (2) 
0.1 % ~1904 
R16 (2) 
0.1 % ~2032 
R16 (2) 
0.1 % 30 
New specie 
2 (2) 1 % 31 
New specie 
2 (2) 1 % 16 
    
John. (3) 
100 %  ~1312         
R16 (2)  
1 % ~310 
New specie 
2 (2) 10 % ~459 
New specie 
2 (2) 10 % ~340 
                        
New specie 
2 (2) 100 % ~1200 
                        
New specie 
2 (3) 1 % ~215 
                  
New specie 
2 (3) 10 % ~956 
New specie 
2 (3) 10 % ~1024 
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Antibacterial effects of marine biological waste products from 
food processing  
Screening for antibacterial effect 
Marine biological waste products from food processing along with honey and 
three strains of B. amyloliquefaciens (5033, 5036 and 5113) were tested for 
antimicrobial activity against four bacteria (P. aeruginosa (two strains), S. aureus 
(two strains), E.coli (two strains) and S. epidermidis (one strain), and two fungi, 
 
Fig. 13 Antimicrobial effect of various substances/microorganisms. 
 The panel show from left to right: the effect of B. amyloliquefaciens strain 5033 against 
Bipolaris sorokiniana, effect of untreated biological waste product 1 upon two strains of 
E. coli, effect of untreated biological waste product 2 on P. aeruginosa, effect of 
untreated biological waste product 1 against both S. aureus. 
 
Bipolaris sorokiniana and Botrytis. Kanamycin and Spectinomycin were used as 
positive controls. Honey had no effect on any microorganism. Of the substances 
only B. amyloliquefaciens strain 5033 had a slight inhibitory effect on Bipolaris. 
None of the substances had a deterrent effect against Botrytis. Marine biological 
waste product 1 that had not been treated in any way had a lytic effect on both 
strains of E.coli. It also had some kind of effect against S. aureus. Marine 
biological waste product 2 was the only one that had an inhibitory effect against 
P. aeruginosa (Fig. 13).  
Although not shown here, both marine biological waste products 1 and 2 
contained some kind of microbes that could grow and compete with the bacteria 
growing on the plates, while not killing the bacteria. 
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Discussion 
Glucosinolates and myrosinase 
Glucosinolates are organic compounds in certain plants whose metabolites 
produced via the degradation by myrosinase have been shown to counteract tumor 
cells in both humans and animals. However, most humans eat their vegetables 
cooked or processed in another way, which is a problem since heating inactivates 
the myrosinase naturally present in the plants. Accordingly, microorganisms 
containing myrosinase might be supplemented to the diet to enhance the 
degradation of glucosinolates in the gut.  
To investigate this possibility several bacteria that have previously been 
reported to express myrosinase activity as well as related bacteria were first tested 
for glucosinolate breakdown via a barium sulfate test. The results were however 
inconclusive since it was almost impossible to determine if there had been 
precipitation due to difficulty in distinguishing between bacterial growth and a 
possible precipitate. It might be that testing for myrosinase activity this way is not 
possible for bacteria or that the medium was not opaque enough. 
Three bacterial species (L. plantarum, L. Johnsonii and L. “new species 2 
rat”) were nonetheless thought to be positive and were further indirectly tested for 
myrosinase activity via measurement of glucose content after incubation of 
bacteria and glucosinolates since one of the breakdown products is glucose. More 
positive results were obtained when the bacteria were incubated with pure sinigrin 
than with mustard extract however the results were so sketchy that it was not 
possible to deduce whether any glucosinolate degradation existed or if the bacteria 
themselves produced glucose via some alternative metabolic pathway.  
Two fungal strains (L. maculans and Botrytis) were also tested for 
glucosinolate degradation. L. maculans only grew on sinigrin media and showed 
obvious precipitation and not on the negative control nor on the other wells 
containing glucosinolate extracts from mustard and various cresses. The negative 
results for the mustard and cress extracts can be either because the extracts did not 
contain enough glucosinolates or that the extracts contained something that 
inhibited the growth of L. maculans. This test should be repeated to see if the 
same results would be obtained. Botrytis did not seem to distinguish between any 
of the samples; it grew on all of them including the negative control. However no 
precipitation could be observed so it might be possible that Botrytis can survive 
via some other metabolic pathway that does not include formation of sulfate. 
Before the bacteria and fungi were grown on the glucosinolate extracts both 
cabbage and mustard extracts were incubated with purified myrosinase before 
detection for glucose to see if they contained glucosinolates. When the mustard 
extracts were tested the flow through fractions contained more glucose than 
elution fraction which was expected since they should have contained naturally 
occurring glucose, however, the amounts in the elution fractions differed between 
mustard batches and even within the same batch when sampled at different times. 
The differences in the elution fractions between the extracts could be due to 
different handling during the extraction process. Nonetheless the changes were so 
minor that they should not have had such an impact upon the glucosinolate 
concentration. Another odd observation was that the glucose content in the elution 
fraction first rose during incubation and peaked at 1 – 2 hours of incubation which 
was expected, yet after this time period the glucose content decreased which was 
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not anticipated since there should not have been anything present in the extract 
that would degrade the glucose. Even if the glucose content did not rise after 2 h it 
should at least have remained constant for the whole duration. An explanation for 
this anomaly could not be deduced. It is possible that these variations were due to 
faulty processing or human error during the measurement. 
To see if the odd results were due to human error or an uncontrolled and 
unknown variable these tests should be redone and the procedures modified.  
Antibacterial effects of marine biological waste products from 
food processing  
Multi-resistant bacteria are a growing global problem and has stimulated intensive 
efforts to find novel antibacterial substances in unlikely and unexplored places 
e.g. from sea living creatures. Field studies had been conducted where it had been 
found that marine biological waste products from food processing had a small 
inhibitory effect upon occurrence of fungi on cereals. 
These substances were tested under in vitro conditions to study if they 
possibly could have an antibacterial effect on human pathogenic bacteria. When 
the bacteria were grown in the presence of the substances it was shown that they 
both had an adverse effect on the bacteria. However, this effect was probably due 
to a biological effect - i.e. some biotic agent(s) was killing/neutralizing the 
bacteria – rather than a chemical effect. This was proven in that the unprocessed 
substances cleared the plates of the bacteria whilst nurturing some other organism 
naturally occurring in the substance, but they had no effect whatsoever when they 
were filtrated before application to the bacteria.  
These substances were also tested unprocessed as well as filtrated on two 
fungal species (B. sorokiniana and Botrytis), but no effect could be observed. This 
lack of effect could be due to that they were only tested on fully grown specimen; 
if they had been tested on spores the results might have been different. While not 
having any effect upon fully formed fungi they might have prevented the spores 
from germinating. 
Since positive results were obtained this research venue should be pursued. 
A way to identify whether the inhibition is due to a chemical or biological agent 
would be to incubate the marine sample with a small amount of desired bacteria in 
a liquid culture. The culture would then be purified and filtrated to remove cells 
and assayed using a diffusion assay to see if the inhibition existed in the filtrate. 
This would enable the microorganisms in the marine sample to react to the 
bacteria before being assayed and thus be able to produce, if possible, an agent 
against the bacteria. This might explain why the filtrated samples did not have an 
effect upon the bacteria while the untreated ones did have one. 
More diffusion screenings should be performed and attempts to isolate the 
active substance should be made. The isolation could be achieved by separating 
the marine sample using thin-layer chromatography, coating the silica plate in 
agar and growing the wanted bacteria on top of the silica plate to observe if any 
inhibition occurs on a specific band. If inhibition occurs that band can be analyzed 
using high performance liquid chromatography and mass spectrometry to identify 
the components in the band. The components should then be individually screened 
against the bacteria to see which is active against the bacteria. If an active 
component is found it should then be screened against known antibacterial 
substances to see if it is an already known compound. If the component is 
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unknown, further testing should be performed to analyze its origin, original 
function and its effect and pathway upon the human pathogenic bacteria. 
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Appendix A 
 
Glucose content in flow through fraction (MF) and elution fraction (ME) in the first mustard 
extract. The numbers are the extract concentration in % and B stands for blank. The concentrations 
are for the diluted extracts. 
 
Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - B 
(nmol) 
                    
Neg. Ctrl 0   0   Neg. Ctrl 0   0   
Stand. 2 0.119   11.1   Stand. 2 0.122   11.1   
Stand. 3 0.159   16.65   Stand. 3 0.175   16.65   
Stand. 5 0.231   27.75   Stand. 5 0.233   27.75   
Stand. 10 0.388   55.5   Stand. 10 0.397   55.5   
Stand. 15 0.785   83.25   Stand. 15 0.544   83.25   
Stand. 20 0.757   111   Stand. 20 0.761   111   
MF 100 0.46 - 58.331 - ME 100 0.514 0.031 73.992 5.046 
MF 100 0.44 - 55.544 - ME 100 0.492 0.009 70.411 1.465 
MF 100 0.402 - 50.248 - ME 100 0.537 0.054 77.737 8.791 
MF 100 0.401 - 50.108 - ME 100 0.561 0.078 81.644 12.698 
MF B100 0.805   106.413   ME B100 0.483   68.946   
MF 75 0.412 - 51.642 - ME 75 0.561 0.009 81.664 1.485 
MF 75 0.46 - 58.331 - ME 75 0.577 0.025 84.248 4.069 
MF 75 0.494 - 63.07 - ME 75 0.567 0.015 82.621 2.442 
MF 75 0.53 - 68.087 - ME 75 0.56 0.008 81.481 1.302 
MF B75 0.693   90.804   ME B75 0.552   80.179   
MF 50 0.777 0.246 102.51 34.284 ME 50 0.627 0.097 92.388 15.791 
MF 50 0.694 0.163 90.943 22.717 ME 50 0.626 0.096 92.226 15.629 
MF 50 0.713 0.182 93.591 25.365 ME 50 0.638 0.108 94.179 17.582 
MF 50 0.764 0.233 100.699 32.473 ME 50 0.626 0.096 92.226 15.629 
MF B50 0.531   68.226   ME B50 0.53   76.597   
MF 25 0.783 0.382 103.347 53.239 ME 25 0.387 0.022 53.317 3.582 
MF 25 0.761 0.36 100.281 50.173 ME 25 0.399 0.034 55.271 5.536 
MF 25 0.748 0.347 98.469 48.361 ME 25 0.381 0.016 52.34 2.605 
MF 25 0.723 0.322 94.985 44.877 ME2 0.354 - 47.945 - 
MF B25 0.401   50.108   ME B25 0.365   49.735   
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Appendix B 
 
Glucose content in flow through fraction (CF) and elution fraction (CE) in the first cabbage 
extract. The numbers are the extract concentration in % and B stands for blank. The concentrations 
are for the diluted extracts. 
 
Sample Mean abs. 
Abs. - 
B abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample. - 
B (nmol) 
                    
Neg. Ctrl 0   0   Neg. Ctrl 0   0   
Stand. 2 0.119   11.1   Stand. 2 0.122   11.1   
Stand. 3 0.159   16.65   Stand. 3 0.175   16.65   
Stand. 5 0.231   27.75   Stand. 5 0.233   27.75   
Stand. 10 0.388   55.5   Stand. 10 0.397   55.5   
Stand. 15 0.785   83.25   Stand. 15 0.544   83.25   
Stand. 20 0.757   111   Stand. 20 0.761   111   
CF 100 1.29 - 174.006 - CE 100 1.782 - 280.419 - 
CF 100 1.501 - 203.412 - CE 100 1.692 - 265.768 - 
CF 100 1.972 - 269.054 - CE 100 1.7 - 267.070 - 
CF 100 2.033 - 277.555 - CE 100 1.768 - 278.140 - 
CF B100 1.996   272.399   CE B100 1.816   285.955   
CF 75 1.834 - 249.821 - CE 75 1.754 - 275.861 - 
CF 75 1.629 - 221.251 - CE 75 1.722 - 270.652 - 
CF 75 1.809 - 246.337 - CE 75 1.926 - 303.862 - 
CF 75 1.696 - 230.589 - CE 75 1.715 - 269.512 - 
CF B 75 1.274   171.776   CE B75 1.62   254.046   
CF 50 0.871 - 115.611 - CE 50 1.615 - 253.232 - 
CF 50 0.798 - 105.437 - CE 50 1.666 - 261.535 - 
CF 50 0.876 - 116.308 - CE 50 1.754 - 275.861 - 
CF 50 0.741 - 97.493 - CE 50 1.624 - 254.697 - 
CF B50 0.987   131.778   CE B50 1.745   274.396   
CF 25 0.568 - 73.383 - CE 25 2.018 - 318.840 - 
CF 25 0.677 - 88.574 - CE 25 2.088 - 330.235 - 
CF 25 0.838 - 111.012 - CE 25 2.113 - 334.305 - 
CF 25 0.824 - 109.061 - CE 25 2.149 - 340.166 - 
CF B25 1.048   140.279   CE B25 2.128   336.747   
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Appendix C 
 
Glucose content in flow through fraction (MF) and elution fraction (ME) in the first concentration 
time line for mustard. The concentrations used were 25% for flow through and 50% for elute. 
Numbers are the incubation time (h) and B stands for blank. The concentrations are for the diluted 
extracts. 
 
Sample Mean abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) Sample 
Mean 
abs. 
Abs. - 
B abs. 
Glucose 
(nmol) 
Sample. - B 
(nmol) 
                    
Neg. Ctrl         Neg. Ctrl         
Stand. 2 0.134   11.10   Stand. 2 0.142   11.10   
Stand. 3 0.162   16.65   Stand. 3 0.180   16.65   
Stand. 5 0.263   27.75   Stand. 5 0.250   27.75   
Stand. 10 0.460   55.50   Stand. 10 0.369   55.50   
Stand. 15 0.645   83,25   Stand. 15 0.456   83.25   
Stand. 20 0.793   111   Stand. 20 0.799   111   
MF 2 1.077 - 149.918 - ME 2 1.505 - 244.417 - 
MF 2 1.151 - 160.898 - ME 2 1.377 - 222.667 - 
MF 2 1.115 - 155.556 - ME 2 1.325 - 213.831 - 
MF 2 1.124 - 156.891 - ME 2 1.226 - 197.008 - 
MF 2B 0.909   124.99   ME 2B 0.951   150.280   
MF 4 1.086 - 151.253 - ME 4 1.237 - 198.878 - 
MF 4 1.089 - 151.698 - ME 4 1.156 - 185.114 - 
MF 4 1.012 - 140.273 - ME 4 1.301 - 209.753 - 
MF 4 0.989 - 136.860 - ME 4 0.934 - 147.391 - 
MF 4B 0.857   117.274   ME 4B 1.214   194.969   
MF 65 1.095 - 152.588 - ME 65 1.135 - 181.545 - 
MF 65 1.162 - 162.530 - ME 65 1.151 - 184.264 - 
MF 65 1.134 - 158.375 - ME 65 1.133 - 181.206 - 
MF 65 1.157 - 161.788 - ME 65 1.095 - 174.749 - 
MF 65B 0.942   129.886   ME 65B 0.991   157.077   
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Appendix D 
 
Glucose content in flow through fraction (CF) and elution fraction (CE) in the first concentration 
time line for cabbage. The concentrations used were 75% for flow through and 75% for elute. 
Numbers are the incubation time (h) and B stands for blank. The concentrations are for the diluted 
extracts. 
 
Sample 
Mean 
abs. 
Abs. - 
B abs. 
Glucose 
(nmol) 
Sample - B 
(nmol) Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - B 
(nmol) 
                    
Neg. Ctrl         Neg. Ctrl         
Stand. 2 0.134   11.10   Stand. 2 0.142   11.10   
Stand. 3 0.162   16.65   Stand. 3 0.180   16.65   
Stand. 5 0.263   27.75   Stand. 5 0.250   27.75   
Stand. 10 0.460   55.50   Stand. 10 0.369   55.50   
Stand. 15 0.645   83.25   Stand. 15 0.456   83.25   
Stand. 20 0.793   111   Stand. 20 0.799   111   
CF 2 2.773 - 401.567 - CE 2 1.765 - 288.597 - 
CF 2 2.800 - 405.573 - CE 2 1.418 - 229.633 - 
CF 2 2.948 - 427.533 - CE 2 1.417 - 229.464 - 
CF 2 2.486 - 358.983 - CE 2 1.375 - 222.327 - 
CF 2B 2.054   294.883   CE 2B 1.353   218.589   
CF 4 2.115 - 303.934 - CE 4 1.328 - 214.340 - 
CF 4 1.970 - 282.419 - CE 4 1.398 - 226.235 - 
CF 4 2.220 - 319.514 - CE 4 1.782 - 291.485 - 
CF 4 2.414 - 348.299 - CE 4 1.476 - 239.489 - 
CF 4B 2.875   416.702   CE 4B 1.467   237.960   
CF 65 2.255 - 324.707 - CE 65 1.286 - 207.204 - 
CF 65 2.125 - 305.418 - CE 65 1.492 - 242.208 - 
CF 65 2.439 - 352.009 - CE 65 1.669 - 272.284 - 
CF 65 2.439 - 352.009 - CE 65 1.398 - 226.235 - 
CF 65B 1.598   227.233   CE 65 1.256   202.106   
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Appendix E 
 
Glucose content in flow through fraction (MF) and elution fraction (ME) in the second 
concentration time line for mustard where the concentration was 10%. Numbers are the incubation 
time (h) and B stands for blank. The concentrations are for the diluted extracts. 
 
Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) 
                    
Neg. Ctrl 0   0   Neg. Ctrl 0   0   
Stand. 2 0.113   11.10   Stand. 2 0.142   11.10   
Stand. 3 0.158   16.65   Stand. 3 0.189   16.65   
Stand. 5 0.249   27.75   Stand. 5 0.257   27.75   
Stand. 10 0.444   55.50   Stand. 10 0.452   55.50   
Stand. 15 0.622   83.25   Stand. 15 0.660   83.25   
Stand. 20 0.811   111   Stand. 20 0.844   111   
MF 0.5 0.577 0.261 76.469 37.634 ME 0.5 0.281 0.044 30.568 6.248 
MF 0.5 0.587 0.271 77.911 39.076 ME 0.5 0.272 0.035 29.290 4.970 
MF 0.5 0.578 0.262 76.613 37.778 ME 0.5 0.271 0.034 29.148 4.828 
MF 0.5 0.562 0.246 74.306 35.471 ME 0.5 0.274 0.037 29.574 5.254 
MF 0.5B 0.316   38.835   ME 0.5B 0.237   24.320   
MF 1 0.571 0.253 75.604 36.481 ME 1 0.380 0.154 44.627 21.869 
MF 1 0.618 0.300 82.381 43.258 ME 1 0.397 0.171 47.041 24.283 
MF 1 0.616 0.298 82.093 42.970 ME 1 0.398 0.172 47.183 24.425 
MF 1 0.400 0.082 50.947 11.824 ME 1 0.263 0.037 28.012 0.710 
MF 1B 0.318   39.123   ME 1B 0.226   22.758   
MF 2 0.507 0.226 66.376 32.588 ME 2 0.258 0.030 27.302 4.260 
MF 2 0.601 0.320 79.930 46.142 ME 2 0.409 0.181 48.745 25.703 
MF 2 0.608 0.092 80.939 47.151 ME 2 0.395 0.167 46.757 23.715 
MF 2 0.618 0.337 82.381 48.593 ME 2 0.414 0.186 49.455 26.413 
MF 2B 0.281   33.788   ME 2B 0.228   23.042   
MF 4 0.516 0.272 67.674 39.221 ME 4 0.252 0.075 26.450 10.650 
MF 4 0.530 0.286 69.692 41.239 ME 4 0.263 0.086 28.012 12.212 
MF 4 0.536 0.292 70.557 42.104 ME 4 0.249 0.072 26.024 10.224 
MF 4 0.532 0.288 69.981 41.528 ME 4 0.259 0.082 27.444 11.644 
MF 4B 0.244   28.453   ME 4B 0.177   15.800   
MF 24 0.470 0.231 61.041 33.309 ME 24 0.228 0.031 23.042 4.402 
MF 24 0.481 0.242 62.627 34.895 ME 24 0.240 0.043 24.746 6.106 
MF 24 0.526 0.287 69.115 41.383 ME 24 0.251 0.054 26.308 7.668 
MF 24 0.505 0.266 66.087 38.355 ME 24 0.240 0.043 24.746 6.106 
MF 24B 0.239   27.732   ME 24B 0.197   18.640   
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Appendix F 
Amount of Glucose in flow through fraction (CF) and elution fraction (CE) in the second 
concentration time line for cabbage where the concentration was 10%. Numbers are the incubation 
time (h) and B stands for blank. The concentrations are for the diluted extracts. 
 
Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) 
                    
Neg. Ctrl 0   0   Neg. Ctrl 0   0   
Stand. 2 0.113   11.10   Stand. 2 0.142   11.10   
Stand. 3 0.158   16.65   Stand. 3 0.189   16.65   
Stand. 5 0.249   27.75   Stand. 5 0.257   27.75   
Stand. 10 0.444   55.50   Stand. 10 0.452   55.50   
Stand. 15 0.622   83.25   Stand. 15 0.660   83.25   
Stand. 20 0.811   111   Stand. 20 0.844   111   
CF 0.5 1.213 - 168.176 - CE 0.5 2.817 - 390.694 - 
CF 0.5 1.220 - 169.186 - CE 0.5 2.338 - 322.673 - 
CF 0.5 1.409 - 196.438 - CE 0.5 2.509 - 346.956 - 
CF 0.5 1.264 - 175.530 - CE 0.5 2.605 - 360.588 - 
CF 0.5B 1.313 - 182.596 - CE 0.5B 2.523 - 348.944 - 
CF 1 0.944 0.164 129.388 23.647 CE 1 2.509 - 346.956 - 
CF 1 0.966 0.186 132.560 26.819 CE 1 2.345 - 323.667 - 
CF 1 0.731 - 98.675 - CE 1 2.433 - 336.164 - 
CF 1 0.931 0.151 127.514 21.773 CE 1 2.511 - 347.240 - 
CF 1B 0.780 - 105.741 - CE 1B 2.467 - 340.992 - 
CF 2 0.821 - 111.652 - CE 2 2.588 - 358.174 - 
CF 2 0.887 - 121.169 - CE 2 2.703 - 374.505 - 
CF 2 0.913 - 124.918 - CE 2 2.526 - 349.370 - 
CF 2 0.722 - 97.377 - CE 2 2.458 - 339.714 - 
CF 2B 1.176 - 162.841 - CE 2B 2.260 - 311.597 - 
CF 4 0.956 0.034 131.119 4.903 CE 4 2.204 - 303.644 - 
CF 4 0.900 - 123.044 - CE 4 2.423 - 334.743 - 
CF 4 0.893 - 122.034 - CE 4 2.323 - 320.543 - 
CF 4 1.127 0.205 155.776 29.560 CE 4 2.359 - 325.655 - 
CF 4B 0.922   126.216   CE 4B 2.296 - 316.709 - 
CF 24 0.779 - 105.596 - CE 24 2.461 - 340.140 - 
CF 24 0.747 - 100.982 - CE 24 1.907 - 261.469 - 
CF 24 0.788 - 106.894 - CE 24 2.138 - 294.272 - 
CF 24 0.745 - 100.694 - CE 24 2.160 - 297.396 - 
CF 24B 0.907 - 124.053 - CE 24B 2.259 - 311.455 - 
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Appendix G 
 
Glucose content in flow through fraction (MF) and elution fraction (ME) in 10% concentration 
time line for mustard extract three. Numbers are the incubation time (h) and B stands for blank. 
The concentrations are for the diluted extracts. 
 
Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample – 
B (nmol) Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) 
                    
Neg. Ctrl    0   Neg. Ctrl     0   
Stand. 2 0.132   11.10   Stand. 2 0.138   11.10   
Stand. 3 0.168   16.65   Stand. 3 0.183   16.65   
Stand. 5 0.262   27.75   Stand. 5 0.368   27.75   
Stand. 10 0.456   55.50   Stand. 10 0.406   55.50   
Stand. 15 0.642   83.25   Stand. 15 0.634   83,25   
Stand. 20 0.656   111   Stand. 20 0.652   111   
MF 0.5 0.113 - 2.803 - ME 0.5 0.138 - 0.961 - 
MF 0.5 0.110 - 2.275 - ME 0.5 0.137 - 0.768 - 
MF 0.5 0.119 - 3.860 - ME 0.5 0.135 - 0.382 - 
MF 0.5 0.123 0.003 4.564 0.528 ME 0.5 0.134 - 0.189 - 
MF 0.5B 0.120 - 4.036   ME 0.5B 0.125 - -1.546   
MF 1 0.135 0.024 6.677 4.226 ME 1 0.118 - -2.896 - 
MF 1 0.132 0.021 6.149 3.698 ME 1 0.119 - -2.703 - 
MF 1 0.127 0.016 5.268 2.817 ME 1 0.121 - -2.318 - 
MF 1 0.114 0.003 2.979 0.528 ME 1 0.119 - -2.703 - 
MF 1B 0.111   2.451   ME 1B 0.116   -3.282   
MF 2 0.120 0.003 4.036 0.529 ME 2 0.120 - -2.511 - 
MF 2 0.136 0.019 6.853 3.346 ME 2 0.122 - -2.125 - 
MF 2 0.137 0.020 7.029 3.522 ME 2 0.120 - -2.511 - 
MF 2 0.135 0.018 6.677 3.170 ME 2 0.116 - -3.282 - 
MF 2B 0.117   3.507   ME 2B 0.115   -3.475   
MF 4 0.111 0.004 2.451 0.705 ME 4 0.115 - -3.475 - 
MF 4 0.114 0.007 2.979 1.233 ME 4 0.111 - -4.246 - 
MF 4 0.110 0.003 2.275 0.529 ME 4 0.113 - -3.860 - 
MF 4 0.112 0.005 2.627 0.881 ME 4 0.114 - -3.668 - 
MF 4B 0.107   1.746   ME 4B 0.117   -3.089   
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Appendix H 
 
Glucose content in flow through fraction (MF) and elution fraction (ME) in 10% concentration 
time line for mustard extract four. Numbers are the incubation time (h) and B stands for blank. The 
concentrations are for the diluted extracts 
 
Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) Sample 
Mean 
abs. 
Abs. - B 
abs. 
Glucose 
(nmol) 
Sample - 
B (nmol) 
                    
Neg. Ctrl 0.187   0   Neg. Ctrl 0.184   0   
Stand. 2 0.237   11.10   Stand. 2 0.250   11.10   
Stand. 3 0.295   16.65   Stand. 3 0.287   16.65   
Stand. 5 0.284   27.75   Stand. 5 0.316   27.75   
Stand. 10 0.510   55.50   Stand. 10 0.563   55.50   
Stand. 15 0.736   83.25   Stand. 15 0.719   83.25   
Stand. 20 0.983   111   Stand. 20 1.020   111   
MF 0.5 0.241 0.033 15.123 4.435 ME 0.5 0.238 0.020 12.714 2.652 
MF 0.5 0.233 0.025 14.048 3.360 ME 0.5 0.236 0.018 12.449 2.387 
MF 0.5 0.208 0 10.688 0 ME 0.5 0.237 0.019 12.582 2.520 
MF 0.5 0.212 0.004 11.225 0.537 ME 0.5 0.234 0.016 12.184 2.122 
MF 0.5B 0.208   10.688   ME 0.5B 0.218   10.062   
MF 1 0.478 0.241 46.977 32.391 ME 1 0.227 0.039 11.256 5.171 
MF 1 0.475 0.238 46.574 31.988 ME 1 0.227 0.039 11.256 5.171 
MF 1 0.449 0.212 43.079 28.493 ME 1 0.145 - 0.384 - 
MF 1 0.235 - 14.317 - ME 1 0.197 0.009 7.278 1.193 
MF 1B 0.237   14.586   ME 1B 0.188   6.085   
MF 2 0.222 - 12.569 - ME 2 0.194 0.016 6.881 2.122 
MF 2 0.452 0.213 43.483 28.629 ME 2 0.226 0.048 11.123 6.364 
MF 2 0.439 0.200 41.735 26.881 ME 2 0.199 0.021 7.543 2.784 
MF 2 0.453 0.214 43.617 28.763 ME 2 0.218 0.040 10.062 5.303 
MF2B 0.239   14.854   ME 2B 0.178   4.759   
MF 3 0.237 0.057 14.586 7.662 ME 3 0.198 - 7.411 - 
MF 3 0.228 0.048 13.376 6.452 ME 3 0.196 - 7.146 - 
MF 3 0.188 0.008 8.000 1.076 ME 3 0.226 0.009 11.123 1.193 
MF 3 0.187 0.007 7.865 0.941 ME 3 0.235 0.018 12.316 2.386 
MF 3B 0.180   6.924   ME 3B 0.217   9.930   
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